A. Gringeri

9.2k total citations
175 papers, 7.0k citations indexed

About

A. Gringeri is a scholar working on Hematology, Genetics and Virology. According to data from OpenAlex, A. Gringeri has authored 175 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Hematology, 33 papers in Genetics and 26 papers in Virology. Recurrent topics in A. Gringeri's work include Hemophilia Treatment and Research (127 papers), Platelet Disorders and Treatments (42 papers) and Blood Coagulation and Thrombosis Mechanisms (36 papers). A. Gringeri is often cited by papers focused on Hemophilia Treatment and Research (127 papers), Platelet Disorders and Treatments (42 papers) and Blood Coagulation and Thrombosis Mechanisms (36 papers). A. Gringeri collaborates with scholars based in Italy, United States and Germany. A. Gringeri's co-authors include Pier Mannuccio Mannucci, LG Mantovani, Elena Santagostino, Sylvia von Mackensen, L Scalone, Jan Astermark, Björn Lundin, Massimo Morfini, Erik Berntorp and W. Schramm and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

A. Gringeri

168 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gringeri Italy 47 5.1k 1.3k 863 862 784 175 7.0k
Paul Giangrande United Kingdom 31 2.8k 0.6× 668 0.5× 1.4k 1.6× 1.4k 1.7× 678 0.9× 103 5.5k
Bruce L. Evatt United States 46 3.7k 0.7× 1.1k 0.8× 578 0.7× 424 0.5× 506 0.6× 150 6.2k
Elena Santagostino Italy 52 8.5k 1.7× 2.1k 1.6× 579 0.7× 514 0.6× 1.4k 1.8× 275 10.1k
C. R. Rizza United Kingdom 34 2.1k 0.4× 554 0.4× 974 1.1× 1.2k 1.3× 869 1.1× 92 4.8k
Edward D. Gomperts United States 32 1.8k 0.4× 502 0.4× 1.3k 1.5× 1.9k 2.2× 746 1.0× 137 5.2k
Margaret W. Hilgartner United States 33 1.9k 0.4× 881 0.7× 1.7k 2.0× 1.1k 1.3× 338 0.4× 116 5.5k
Margaret V. Ragni United States 47 4.7k 0.9× 1.2k 0.9× 383 0.4× 637 0.7× 2.4k 3.1× 280 9.8k
M. Elaine Eyster United States 34 1.5k 0.3× 474 0.4× 597 0.7× 1.1k 1.3× 386 0.5× 124 5.1k
Patricia E. Taylor United States 22 1.1k 0.2× 454 0.3× 735 0.9× 151 0.2× 276 0.4× 48 3.2k
C A Ludlam United Kingdom 23 910 0.2× 304 0.2× 231 0.3× 632 0.7× 211 0.3× 54 2.9k

Countries citing papers authored by A. Gringeri

Since Specialization
Citations

This map shows the geographic impact of A. Gringeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gringeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gringeri more than expected).

Fields of papers citing papers by A. Gringeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gringeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gringeri. The network helps show where A. Gringeri may publish in the future.

Co-authorship network of co-authors of A. Gringeri

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gringeri. A scholar is included among the top collaborators of A. Gringeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gringeri. A. Gringeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Candura, Fabio, et al.. (2026). Launch of a National Registry for Congenital Hematological Disorders in Palestine: the Haemo-PAL Initiative. SHILAP Revista de lepidopterología. 5(1).
2.
Oldenburg, Johannes, Kate Khair, M. G. Mazzucconi, et al.. (2017). Real World Prospective Data on Bleeding Frequency in 1,000 Patients with Hemophilia a - is the Goal of Zero Bleeds Achievable?. Haemophilia. 4 indexed citations
3.
Klamroth, Robert, Kate Khair, Karin Kurnik, et al.. (2016). Striving for a Bleed Free World - An Interim Analysis from the AHEAD Study. Haemophilia. 1 indexed citations
4.
Mackensen, Sylvia von, Silvia Riva, Kate Khair, et al.. (2013). Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL). Value in Health. 16(3). A196–A196. 4 indexed citations
5.
Cadeddu, Chiara, Stefano Capri, Chiara de Waure, et al.. (2012). Cost of Illness Analysis of Hemophilia A: Resources Use and Direct Costs in Italy. Haemophilia. 18. 70–70. 1 indexed citations
6.
Gringeri, A., Björn Lundin, Sylvia von Mackensen, LG Mantovani, & Pier Mannuccio Mannucci. (2011). A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). Journal of Thrombosis and Haemostasis. 9(4). 700–710. 364 indexed citations
7.
Gringeri, A., Björn Lundin, Sylvia von Mackensen, LG Mantovani, & P.M. Mannucci. (2008). A 10-year, randomized, clinical trial on prophylaxis vs. on-demand treatment in children with haemophilia A: the E.S.P.R.I.T. study. Lund University Publications (Lund University). 4 indexed citations
8.
Bullinger, Monika, A. Gringeri, & Sylvia von Mackensen. (2008). Lebensqualität von jungen Patienten mit Hämophilie in Europa. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 51(6). 637–645. 4 indexed citations
9.
Mannucci, Pier Mannuccio, A. Gringeri, Flora Peyvandi, & Elena Santagostino. (2007). Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma‐product exposed toddlers). Haemophilia. 13(s5). 65–68. 66 indexed citations
10.
Scalone, L, et al.. (2006). Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia. 12(2). 154–162. 123 indexed citations
11.
Gringeri, A., Sylvia von Mackensen, Günter Auerswald, et al.. (2004). Health status and health‐related quality of life of children with haemophilia from six West European countries. Haemophilia. 10(s1). 26–33. 91 indexed citations
12.
Gringeri, A., et al.. (2004). Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain‐deleted recombinant factor VIII. British Journal of Haematology. 126(3). 398–404. 33 indexed citations
13.
Gringeri, A., et al.. (2003). PHL9 APPLICATION OF CONJOINT ANALYSIS TO ELICIT PREFERENCES IN HEMOPHILIA CARE: THE CONAN STUDY GROUP. Value in Health. 6(6). 743–743. 1 indexed citations
14.
Ghio, Massimo, Paola Contini, Luciano Ottonello, et al.. (2003). Effect of clotting factors concentrates on lymphocyte and neutrophil function in vitro. Thrombosis and Haemostasis. 89(2). 365–373. 10 indexed citations
15.
Gringeri, A., Elena Santagostino, Hélène Le Buanec, et al.. (1999). Tat Toxoid as a Component of a Preventive Vaccine in Seronegative Subjects. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(4). 371–375. 28 indexed citations
16.
Buanec, Hélène Le, A Lachgar, B Bizzini, et al.. (1998). A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid. Biomedicine & Pharmacotherapy. 52(10). 431–435. 12 indexed citations
17.
Catania, Anna, et al.. (1998). Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients. Peptides. 19(6). 1099–1104. 28 indexed citations
18.
19.
Costa, John J., George D. Demetri, Terence J. Harrist, et al.. (1996). Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.. The Journal of Experimental Medicine. 183(6). 2681–2686. 209 indexed citations
20.
Gringeri, A., et al.. (1990). High-purity factor VIII concentrates produced without using monoclonal antibodies. La Ricerca in Clinica e in Laboratorio. 20(4). 227–37. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Giangrande Breakdown of academic impact, for papers by Bruce L. Evatt Breakdown of academic impact, for papers by Elena Santagostino Breakdown of academic impact, for papers by C. R. Rizza Breakdown of academic impact, for papers by Edward D. Gomperts Breakdown of academic impact, for papers by Margaret W. Hilgartner Breakdown of academic impact, for papers by Margaret V. Ragni Breakdown of academic impact, for papers by M. Elaine Eyster Breakdown of academic impact, for papers by Patricia E. Taylor Breakdown of academic impact, for papers by C A Ludlam
Rankless by CCL
2026